Showing 221–240 of 258 results  
ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer – PRNewswire *  Vaccine summit exceeds target to raise almost £7bn *  Novacyt sees more wins for coronavirus test product *  Cleveland Metroparks opens shoreline attractions, swimming areas: What to know *  La oca de la desescalada * 
Gfinity signs five-year deal with Abu Dhabi Motorsport Management *  Nightfall *  Ex-Store – Soutien-gorge de tous les jours – Femme *  Coronavirus: Germany reopens shops as lockdown is relaxed *  India’s Glenmark to study potential COVID-19 drug combination *